£64.53

It has never been this cheap. We have no record of a lower price.

£65 today · cheaper than every other day in the last 3 months

Springer Atypical Breast Proliferative Lesions and Benign Breast Disease

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£64.53 £61.30 £62.59 £63.88 £65.18 £66.47 £67.76 22 August 2026 06 September 2026 21 September 2026 06 October 2026 22 October 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 1 price levels

Days at Price
62 days 0 16 31 47 62 £65 Days at Price

Price Analysis

Most common price: £65 (62 days, 100.0%)

Price range: £65 - £65

Price levels: 1 different prices over 62 days

Description

Management of atypical breast lesions continues to evolve. There is considerable controversy as to whether these entities represent risk factors for future breast cancer or whether they are instead precursor lesions. A better understanding of the prognostic and therapeutic implications of each of these lesions is important for assessing subsequent breast cancer risk. Risk assessment tools are available for screening high risk patients and understanding the utility and limitations of these tools is important for all clinicians involved in the care of patients. There have been significant advances in breast cancer screening in the last several year including breast tomosynthesis, automated breast ultrasound, molecular imaging, as well as accelerated breast MRI protocols. This has raised the question: Do women at risk for breast cancer need additional breast cancer screening using these newer imaging modalities? In addition, with these advancesin imaging, can women with atypical proliferative lesions be observed rather than undergoing surgical excision as some suggest? The role of observation, surgical excision and even prophylactic mastectomy in women with atypical proliferative lesions continues to be debated; however there is data that can guide physicians in the management of these patients. Pleomorphic Lobular carcinoma in-situ (PLCIS) is a distinct pathological entity within LCIS and there is no consensus regarding surgical margins or the need for adjuvant treatment to prevent recurrence. Recently, ductal carcinoma in-situ (DCIS) has been the subject of much controversy: is it truly a cancer or is it instead a precursor lesion. The traditional management of DCIS with lumpectomy and radiation is now being debated and recent data demonstrates that low grade DCIS can be managed with observation. Clinical trials are now accruing patients with low and intermediate grade DCIS to observation and closesurveillance, and not surgical excision. Finally, new guidelines for chemoprevention with the use of tamoxifen and raloxifen for women with atypical proliferative lesions, LCIS, PLCIS, and DCIS are available and should be discussed as an option when guiding management of these patients. This book will provide a comprehensive review of this field and will serve as a valuable resource for clinicians, general surgeons, breast surgeons and surgical oncologists, as well as researchers with an interest in the management of atypical breast lesions. The book will review new data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions. Our text will provide assessment tools for risk prediction of breast cancer. We will provide data on thecurrent imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. For ductal carcinoma in-situ, the debate continues in regards to whether this disease entity is a precursor lesion that can be managed with observation or hormonal therapy, or is DCIS cancer and treated with lumpectomy and radiation. Several studies have been published where patients are managed with observation and treatment with hormonal therapy before surgical management. New trials have already begun accruing patients with low to intermediate grade DCIS where patients will be managed with observation versus hormonal therapy only. Management of DCIS continues to evolve and current management will be discussed This text will provide a concise but comprehensive summary of the current management of patients with atypical breast proliferative lesions and some benign breast lesions and will help guided management of these patients. All chapters in this text will be written by experts in the field in each of these disease entities. They will all include the most up to date research and clinical information to enhance our understanding and treatment of patients.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
10 October 2018
Listed Since
26 April 2018

Barcode

No barcode data available

Similar Products You Might Like

Breast Pathology: Problematic Issues
86% match

Breast Pathology: Problematic Issues

Springer

£117.61 23 Oct 2026
Non-Disseminated Breast Cancer: Controversial Issues in Management (Medical Radiology)
83% match

Non-Disseminated Breast Cancer: Controversial Issues in Management (Medical Radiology)

Springer

£76.42 24 Oct 2026
Diseases of the Breast during Pregnancy and Lactation: 1252 (Advances in Experimental Medicine and Biology, 1252)
83% match

Diseases of the Breast during Pregnancy and Lactation: 1252 (Advances in Experimental Medicine and Biology, 1252)

Springer

£92.22 27 Oct 2026
Breast Cancer Risk Reduction and Early Detection
83% match

Breast Cancer Risk Reduction and Early Detection

Springer

£79.70 26 Oct 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
83% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£86.76 27 Oct 2026
Practical Atlas of Breast Pathology
83% match

Practical Atlas of Breast Pathology

Springer

£231.97 20 Oct 2026
Prognostic variables in node-negative and node-positive breast cancer
82% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£166.90 23 Oct 2026
Minimally Invasive Breast Biopsies: 173 (Recent Results in Cancer Research, 173)
82% match

Minimally Invasive Breast Biopsies: 173 (Recent Results in Cancer Research, 173)

Springer

£123.48 13 Nov 2026
Breast Cancer Screening and Diagnosis: A Synopsis
82% match

Breast Cancer Screening and Diagnosis: A Synopsis

Springer

£81.74 24 Oct 2026
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
82% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£162.32 22 Oct 2026
Atlas of Differential Diagnosis in Breast Pathology (Atlas of Anatomic Pathology)
81% match

Atlas of Differential Diagnosis in Breast Pathology (Atlas of Anatomic Pathology)

Springer

Price unavailable
A Practical Guide to Breast Cancer Treatment
81% match

A Practical Guide to Breast Cancer Treatment

Springer

£115.72 22 Oct 2026
Breast Care: A Clinical Guidebook for Women’s Primary Health Care Providers
81% match

Breast Care: A Clinical Guidebook for Women’s Primary Health Care Providers

Springer

£110.25 20 Oct 2026
Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)
81% match

Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)

Springer

£78.17 22 Oct 2026
Management of Thyroid Nodules and Differentiated Thyroid Cancer: A Practical Guide
81% match

Management of Thyroid Nodules and Differentiated Thyroid Cancer: A Practical Guide

Springer

£89.28 22 Oct 2026
Imaging-Guided Interventional Breast Techniques
81% match

Imaging-Guided Interventional Breast Techniques

Springer

£118.40 27 Oct 2026
Managing Common and Uncommon Complications of Aesthetic Breast Surgery
80% match

Managing Common and Uncommon Complications of Aesthetic Breast Surgery

Springer

£79.70 27 Oct 2026
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options
80% match

Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options

Springer

£60.47 27 Oct 2026
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer: 195 (Recent Results in Cancer Research, 195)
80% match

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer: 195 (Recent Results in Cancer Research, 195)

Springer

£80.67 23 Oct 2026
Prolactin Disorders: From Basic Science to Clinical Management (Contemporary Endocrinology)
80% match

Prolactin Disorders: From Basic Science to Clinical Management (Contemporary Endocrinology)

Humana

£73.14 26 Oct 2026
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
80% match

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Springer

£80.67 21 Oct 2026
Breast Cancer Diagnosis
80% match

Breast Cancer Diagnosis

Springer

£76.42 24 Oct 2026
Interventional Breast Imaging: Ultrasound, Mammography, and MR Guidance Techniques
80% match

Interventional Breast Imaging: Ultrasound, Mammography, and MR Guidance Techniques

Thieme

£87.53 22 Oct 2026
Imaging-Guided Interventional Breast Techniques
80% match

Imaging-Guided Interventional Breast Techniques

Springer

£147.86 23 Oct 2026